By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
PratapDarpanPratapDarpanPratapDarpan
  • Top News
  • India
  • Buisness
    • Market Insight
  • Entertainment
    • CELEBRITY TRENDS
  • World News
  • LifeStyle
  • Sports
  • Gujarat
  • Tech hub
  • E-paper
Reading: AI 5 million enables lung cancer signs, initial diagnosis capable
Share
Notification Show More
Font ResizerAa
Font ResizerAa
PratapDarpanPratapDarpan
  • Top News
  • India
  • Buisness
  • Entertainment
  • World News
  • LifeStyle
  • Sports
  • Gujarat
  • Tech hub
  • E-paper
Search
  • Top News
  • India
  • Buisness
    • Market Insight
  • Entertainment
    • CELEBRITY TRENDS
  • World News
  • LifeStyle
  • Sports
  • Gujarat
  • Tech hub
  • E-paper
Have an existing account? Sign In
Follow US
  • Contact Us
  • About Us
  • About Us
  • Privacy Policy
  • Privacy Policy
© 2022 Foxiz News Network. Ruby Design Company. All Rights Reserved.
PratapDarpan > Blog > Lifestyle > AI 5 million enables lung cancer signs, initial diagnosis capable
Lifestyle

AI 5 million enables lung cancer signs, initial diagnosis capable

PratapDarpan
Last updated: 1 May 2025 19:04
PratapDarpan
1 month ago
Share
AI 5 million enables lung cancer signs, initial diagnosis capable
SHARE

Contents
AI 5 million enables lung cancer signs, initial diagnosis capableUsing Artificial Intelligence, the new technology operated 5 million chest X-rays in more than 20 countries, which helped early 50,000 people to an early signs of lung cancer. This low -cost method helps doctors to find cancer faster.

AI 5 million enables lung cancer signs, initial diagnosis capable

Using Artificial Intelligence, the new technology operated 5 million chest X-rays in more than 20 countries, which helped early 50,000 people to an early signs of lung cancer. This low -cost method helps doctors to find cancer faster.

The screening program analyzed chest X-rays to identify abnormalities such as high-risk lung nodules.
The screening program analyzed chest X-rays to identify abnormalities such as high-risk lung nodules. (Photo: Getty Image)

A new technology examined the chest X-rays of 5 million people in 20 countries and successfully detected early signs of lung cancer using artificial intelligence.

AII algorithm, developed through a collaboration between Astrazenca and Indian Health -Technical Company Qure.AI, analyzed the scan done in Asia, Middle East, Africa and Latin America – areas where access to advanced clinical devices are often limited.

Astrazheneka, a global bioframacutical company with a headquarters in the UK, is known for developing life-saving treatment in oncology, heart and respiratory diseases. It participated with Qure.Aai, so that they could deploy the AI ​​tool in the resource-granting settings, so that the initial cancer can be more accessible than the detection.

The screening program used Qure.Ai’s ownership algorithm, QXR, which analyzed chest X-rays to identify abnormalities, especially high-risk lung nodules that could indicate early stage cancer.

AI then flagged off these cases for a follow-up diagnostic test like CT scan. So far, around 50,000 people with suspected nodules have been referred to for further testing, enabling earlier diagnosis and rapid intervention.

“Reaching the five million scan milestones to change cancer’s care is a demonstration of digital innovation power. AI-competent equipment like QXR is proving to be a cost-effective way to screen for lung cancer, where radiologists or advanced imaging facilities cannot be easily available,” TI Haveli said that TI Haveli said that International Oncology is the Deputy Speaker of International Oncology.

Qure.ai CEO Prashant Warrier said that this collaboration has helped to score its AI technology in the real world clinical environment. “This milestone shows how AI can bridge the difference in access to healthcare and strengthen the system through rapid diagnosis,” he said.

Lung cancer has become a major cause of cancer-related deaths worldwide, especially in low and medium-oriented countries. In these areas, where screening programs often decrease, technology such as QXR further provides a promising method.

A recent study presented in the European Lung Cancer Congress 2025 found that QXR successfully identified high -risk nodules in 54.1% of cases, highlighting its utility as a frontline screening tool.

With this, Astrazeneca and Qure.AI are now working with local governments and health agencies to expand the access to the AI-operated screening and bring the diagnosis of lung cancer on time to more weak communities.

You Might Also Like

The lawyer quit his job to sell mac and cheese. he is now a millionaire
A1 and A2 milk products like ghee are ‘misleading’. Know why
Paracetamol overdose: how much is too much?
World Bicycle Day 2024: Date, History, Significance and Everything You Need to Know
What to eat before your period to avoid mood
Share This Article
Facebook Email Print
Previous Article From Old Country Bumpkin to Master Swordsman Episode 5: Beril Save Mevi; Repetition, release date and more From Old Country Bumpkin to Master Swordsman Episode 5: Beril Save Mevi; Repetition, release date and more
Next Article જીએસટી કલેક્શન એપ્રિલમાં રૂ. 2.37 લાખ કરોડનો રેકોર્ડ બનાવ્યો, 12.6% સુધી જીએસટી કલેક્શન એપ્રિલમાં રૂ. 2.37 લાખ કરોડનો રેકોર્ડ બનાવ્યો, 12.6% સુધી
Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

about us

We influence 20 million users and is the number one business and technology news network on the planet.

Find Us on Socials

© Foxiz News Network. Ruby Design Company. All Rights Reserved.
Join Us!
Subscribe to our newsletter and never miss our latest news, podcasts etc..

Subscribe my Newsletter for new blog posts, tips & new photos. Let's stay updated!

Zero spam, Unsubscribe at any time.
Go to mobile version
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up